No photo of Paola Caroli

View Scopus Profile

Paola Caroli

  • 372 Citations
  • 9 h-Index
20102018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paola Caroli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Castration Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Fluorodeoxyglucose F18 Medicine & Life Sciences
Peptide Receptors Medicine & Life Sciences
Radioisotopes Medicine & Life Sciences
Carcinoid Tumor Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

  • 372 Citations
  • 9 h-Index
  • 17 Article
  • 1 Chapter

68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients

Caroli, P., Sandler, I., Matteucci, F., De Giorgi, U., Uccelli, L., Celli, M., Foca, F., Barone, D., Romeo, A., Sarnelli, A. & Paganelli, G., Jun 19 2018, In : European Journal of Nuclear Medicine and Molecular Imaging.

Research output: Contribution to journal › Article

Prostatic Neoplasms
Recurrence
Therapeutics
Prostate-Specific Antigen
Choline
3 Citations (Scopus)

Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer

Conteduca, V., Scarpi, E., Caroli, P., Salvi, S., Lolli, C., Burgio, S. L., Menna, C., Gurioli, G., Schepisi, G., Testoni, S., Paganelli, G., Casadio, V., Matteucci, F. & De Giorgi, U., Nov 14 2017, In : Scientific Reports. 7, 1, p. 15541

Research output: Contribution to journal › Article

Castration
Androgen Receptors
Prostatic Neoplasms
Choline
Therapeutics
4 Citations (Scopus)

Prognostic value of 18F–choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

Caroli, P., de Giorgi, U., Scarpi, E., Fantini, L., Moretti, A., Galassi, R., Celli, M., Conteduca, V., Rossi, L., Bianchi, E., Paganelli, G. & Matteucci, F., Nov 6 2017, (Accepted/In press) In : European Journal of Nuclear Medicine and Molecular Imaging. p. 1-7 7 p.

Research output: Contribution to journal › Article

Castration
docetaxel
Prostatic Neoplasms
Androgen Antagonists
Multivariate Analysis
9 Citations (Scopus)

Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results

Matteucci, F., Caroli, P., Di Iorio, V., Sarnelli, A., Celli, M., Fantini, L., Moretti, A., Galassi, R., de Giorgi, U. & Paganelli, G., Aug 11 2017, (Accepted/In press) In : European Journal of Nuclear Medicine and Molecular Imaging. p. 1-6 6 p.

Research output: Contribution to journal › Article

Mannitol
Kidney
Osmotic Diuretics
human glutamate carboxypeptidase II
Lacrimal Apparatus

Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PET

Ianniello, A., Sansovini, M., Severi, S., Nicolini, S., Grana, C. M., Massri, K., Bongiovanni, A., Antonuzzo, L., Di Iorio, V., Sarnelli, A., Caroli, P., Monti, M., Scarpi, E. & Paganelli, G., Jun 2016, In : European Journal of Nuclear Medicine and Molecular Imaging. 43, 6, p. 1040-6 7 p.

Research output: Contribution to journal › Article

Peptide Receptors
Carcinoid Tumor
Radioisotopes
Disease-Free Survival
Therapeutics